Fibromyalgia
Conditions
Keywords
fibromyalgia, ribose, d-ribose, dextrose
Brief summary
The purose of this research study is to determine the potential benefit of D-ribose, a nutritional supplement (a sugar), versus a placebo (another sugar) in people with fibromyalgia.
Detailed description
Two hundred to three hundred subjects (equally distribued between placebo and D-ribose) between 18-78 years of age will comprise this study. The final numbers enrolled will depend upon obtaining approximately 100 subjects that can display a high degree of compliance to TID dosing with approximately equal balance between the active and placebo arms.
Interventions
DIETARY_SUPPLEMENTD-ribose
5 grams administered orally TID
OTHERdextrose
5 grams orally TID
Sponsors
Bioenergy Life Science, Inc.
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 78 Years
Healthy volunteers
No
Inclusion criteria
* previous diagnosis of fibromomyalgia by a MD * Has been diagnosed with fibromyalgia and are over 18 years of age * Does live in the United States
Exclusion criteria
* does NOT have severe medication/chemical/supplement sensitivities * does NOT have insulin dependent diabetes or other severe illnesses (cancer, hepatitis, congestive heart failure) * does NOT have rheumatoid arthritis or gout * previous use of ribose
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Significant reduction in symptoms of pain and fatigue | 3 weeks |
Secondary
| Measure | Time frame |
|---|---|
| Demonstrate an improvement in ones quality of life | 3 weeks |
Countries
United States
Outcome results
None listed